During development, inhibitor of DNA binding (Id) proteins, a subclass of the helix-loop-helix family of proteins, regulate cellular proliferation, differentiation, and apoptosis in various organs. However, a functional role of Id2a in liver development has not yet been reported. Here, using zebrafish as a model organism, we provide in vivo evidence that Id2a regulates hepatoblast proliferation and cell death during liver development. Initially, in the liver, id2a is expressed in hepatoblasts and after their differentiation, id2a expression is restricted to biliary epithelial cells. id2a knockdown in zebrafish embryos had no effect on hepatoblast specification or hepatocyte differentiation. However, liver size was greatly reduced in id2a morpholino-injected embryos, indicative of a hepatic outgrowth defect attributable to the significant decrease in proliferating hepatoblasts concomitant with the significant increase in hepatoblast cell death. Altogether, these data support the role of Id2a as an important regulator of hepatic outgrowth via modulation of hepatoblast proliferation and survival during liver development in zebrafish.
Introduction
Liver organogenesis is a multifaceted process involving hepatoblast specification from the ventral foregut endoderm, budding and outgrowth of the liver bud, and hepatoblast differentiation into either hepatocytes or biliary epithelial cells (BECs) (Zaret, 2002; Lemaigre, 2003) . In both mice (Jung et al., 1999; Rossi et al., 2001 ) and zebrafish (Shin et al., 2007; , inductive signals of Fibroblast Growth Factors (FGFs) and Bone Morphogenetic Proteins (BMPs) are essential for hepatoblast specification. In conjunction with the BMP and FGF signaling pathways, several homeobox transcription factors, including HHEX and PROX1, also regulate the initial stages of liver organogenesis (Si-Tayeb et al., 2010) . HHEX regulates hepatoblast proliferation and delamination from the foregut endoderm as Hhex −/− mice lack a liver bud and the hepatoblasts fail to migrate into the surrounding septum transversum mesenchyme (Bort et al., 2004) . PROX1 also regulates hepatoblast delamination from the liver diverticulum as hepatoblasts fail to migrate in Prox1 −/− mice (Sosa-Pineda et al., 2000) . Hepatocyte metabolic gene expression is altered in favor of biliary gene expression when Prox1 is ablated in post-delaminated hepatoblasts (Seth et al., 2014) . hhex (Wallace et al., 2001 ) and prox1a also regulate liver development in zebrafish. prox1a, specifically, marks the initiation of hepatoblast specification in zebrafish (Ober et al., 2006) . Besides HHEX and PROX1, zebrafish and mammals share additional transcription factors critical for liver organogenesis, such as GATA6 and hepatic nuclear factors (HNFs) (Bossard and Zaret, 1998; Matthews et al., 2004; Holtzinger and Evans, 2005; Lokmane et al., 2008) . However, a comprehensive understanding of the molecular mechanisms underlying transcriptional regulation during liver development still needs to be defined.
One family of transcriptional regulators essential in developmental processes, including cell lineage commitment, proliferation and differentiation, is the helix-loop-helix (HLH) family of transcription factors (Massari and Murre, 2000; Jones, 2004) . The HLH domain, essential for dimerization, is important in the formation of homo-or hetero-dimers. While some HLH proteins are ubiquitously expressed (e.g., E proteins), other HLH proteins are tissue-specific (e.g., PTF1, HES1). HES1, in particular, downstream of Notch signaling, is essential for digestive system development, especially in extrahepatic bile duct development (Sumazaki et al., 2004) . In Hes1 −/− mice, no tubular structures form in the ductal plate during intrahepatic bile duct development (Kodama et al., 2004) . In addition, the bHLH factor, heart and neural crest derivatives expressed 2 (Hand2), is expressed in tissues that surround the liver primordium, such as the lateral plate mesoderm in zebrafish, which later contributes to the hepatic stellate cells (Yin et al., 2012) . Moreover, bHLH-PAS (Per-ARNT-Sim) factors, such as the hypoxia inducible factors (HIFs), participate in hepatic disease, regeneration, fibrosis, and hepatocellular carcinoma (Nath and Szabo, 2012) . Hif2α (renamed as Epas1b) binds hypoxia response elements (HREs) and regulates hepatic outgrowth in zebrafish (Lin et al., 2014) . The activity of bHLH factors can be regulated by the inhibitor of DNA binding (ID) family of proteins.
ID proteins lack the basic DNA binding domain and regulate HLH factors via heterodimerization and subsequent creation of nonfunctional, dominant negative complexes that lack DNA-binding capability (Norton, 2000) . By heterodimerizing and sequestering ubiquitously expressed HLH factors, such as E-proteins (E47, E2-2, HEB, E12), or tissue-restricted HLH factors, ID proteins can thereby regulate cell proliferation, differentiation and apoptosis in a cell-context dependent manner (Sikder et al., 2003) . In the pancreas, for instance, by binding and sequestering NeuroD, a bHLH factor implicated in pancreatic beta cell survival and differentiation, ID2 regulates pancreatic progenitor expansion (Hua et al., 2006) . Non-bHLH factors can also bind and regulate ID protein function. For example, hypophosphorylated Retinoblastoma (Rb) tumor-suppressor protein interacts with ID2 during cell cycle arrest, preventing the latter from sequestering other transcription factors and consequently allows differentiation to occur (Iavarone et al., 1994; Lasorella et al., 2002) . Mice with a genetic deletion of Id2 display a reduced number of natural killer cells, lack lymph nodes and experience 25% neonatal lethality (Yokota et al., 1999) . To date, no study has examined the role of ID2 in hepatogenesis.
While the mammalian genome consists of four Id genes, Id1-4 (Lasorella et al., 2014) , five id genes are present in the zebrafish genome: id1, id2a, id2b, id3, and id4. In the developing zebrafish liver, we observed that among the five id genes, only id2a is restrictively expressed in BECs. This unique expression pattern prompted us to investigate the function of id2a in liver development. Here, we show that initially, id2a is expressed in hepatoblasts and later, in BECs. In addition, using the morpholino knockdown approach, we show that Id2a regulates hepatic outgrowth, without affecting hepatoblast specification or differentiation, by modulating hepatoblast proliferation and survival.
Results

id2a expression in the developing liver
Using whole-mount in situ hybridization (WISH), we examined id2a expression during liver development in detail. We first detected id2a expression in the liver-forming region from 30 hours post fertilization (hpf) (Fig. 1A) , when hepatoblast specification has already occurred. At this stage, the liver tissue consists of hepatoblasts, which are liver progenitor cells, capable of differentiating into either hepatocytes or BECs. Following hepatoblast differentiation, around 72 hpf, we noted that id2a expression displayed a branching pattern in the liver, indicative of the intrahepatic biliary network consisting of BECs. The BEC-specific expression was maintained even at 5 days post fertilization (dpf) (Fig. 1A) . To confirm id2a expression in BECs, we conducted immunostaining in conjunction with WISH utilizing the Tg(prox1a:YFP), Tg(Tp1:GFP), and Tg(kdrl:GFP) lines, which express fluorescent proteins in hepatoblasts (Bussmann and Schulte-Merker, 2011) , BECs (Parsons et al., 2009) , and liver endothelial cells (Beis et al., 2005) , respectively. As initially observed, id2a was specifically detected in prox1a:YFP-positive (Fig. 1B) and Tp1:GFP-positive cells (Fig. 1C) , but not in the endothelial cells (Fig. 1D ), indicating that in the liver, id2a is initially expressed in hepatoblasts and later restricted to BECs.
Since the zebrafish genome contains five id genes, we further investigated the expression patterns of the remaining four id genes, id1, id2b, id3, and id4, in the liver during embryonic development. At 30 hpf, id2b, id3, and id4 are not expressed in the liver-forming region; however, it was not clear whether id1 is expressed in the liver-forming region due to its broad expression ( Fig. 2A) . Double labeling of id1 and sox17:GFP, which labels all endodermal cells , showed id1 expression in the liver-forming region ( Fig. 2E ; brackets). At 48 hpf, none of the four genes are expressed in the liver. At 72 hpf, id2b, and id3, but not id1 or id4, are expressed in the liver ( Fig. 2B and C; arrows); however, their expression does not mimic the biliary branching pattern of id2a expression. Altogether, these expression data indicate that both id1 and id2a are expressed in the liver-forming region at 30 hpf and that only id2a expression is restricted to BECs.
id2a knockdown causes an intrahepatic biliary network defect in the developing liver
Given the restricted expression pattern of id2a in BECs, we sought to determine whether id2a is important for intrahepatic biliary development. We conducted loss-of-function analyses using published id2a morpholino oligonucleotides (MO) (Uribe and Gross, 2010; Das and Crump, 2012; Uribe et al., 2012) . Consistent with previous reports, id2a MO-injected embryos were microcephalic and microphthalmic (Uribe and Gross, 2010) , a phenotype also observed in Id2 −/− mice (Yokota et al., 1999) . Importantly, the small liver phenotype observed in id2a MO-injected embryos was partially rescued by id2a mRNA injection ( Fig. S1A and S1B ), further validating the id2a MO. Since id2a is expressed specifically in BECs at later stages of liver development, we used the Tg(Tp1:GFP) line to examine BECs. Using epifluorescence microscopy, we detected very few GFP-positive cells in the livers of id2a MO-injected embryos ( Fig. 3A; squares), suggesting BEC number was greatly reduced. To further analyze the intrahepatic biliary structure, whole-mount immunostaining combined with confocal microscopy was used. In id2a MO-injected embryos, not only was the liver size reduced, but the intrahepatic biliary network failed to branch, appearing aggregated (Fig. 3B) . Taken together, these data imply that lack of id2a results in defective biliary structure and reduced BEC number, suggesting that id2a may regulate intrahepatic biliary development.
id2a knockdown reduces liver size but does not block hepatoblast specification or hepatocyte differentiation
The main steps of liver development include hepatic competence, hepatoblast specification, hepatocyte or BEC differentiation, and hepatic outgrowth (Zaret, 2002) . Since id2a is expressed in the liver-forming region from 30 hpf (Fig. 1A) after hepatoblast specification, which occurs around 22 hpf in zebrafish (Ober et al., 2006) , it is unlikely that Fig. 3 . id2a knockdown reduces liver size but does not block hepatoblast specification or hepatocyte differentiation. (A) Epifluorescence images revealing a decreased number of Tp1:GFP + BECs in the liver of id2a MO-injected embryos at 72 hpf compared with controls (squares). Higher magnification images of the square regions are shown in insets. Lateral view, anterior to the left. (B) Confocal projection images revealing fabp10a:dsRed (hepatocytes; red), Tp1:GFP (BECs; green) and Anxa4 (the hepatopancreatic ductal system; blue) expression (Zhang et al., 2014) . In id2a MO-injected embryos, liver size was greatly reduced and intrahepatic BECs appeared aggregated, displaying a branching defect. (C-H) id2a MO-injected and uninjected control embryos were processed for WISH with hhex (C), prox1a (D), fabp10a (E), cp (F), sepp1b (G), and cdx1b (H) probes. Overall liver size was greatly reduced in id2a MO-injected embryos as revealed by the hepatoblast markers (hhex and prox1a) and the hepatocyte markers (fabp10a, cp, and sepp1b). However, the expression of these genes was clearly detected in the MO-injected embryos (C-G, arrows), indicating normal hepatoblast specification and hepatocyte differentiation upon id2a knockdown. The induction of the intestinal bulb as assessed by cdx1b expression appeared normal in id2a MO-injected embryos at 36 hpf; however, the intestinal bulb failed to grow at 48 hpf (H, brackets). id2a is implicated in hepatic competence. Thus, we examined the expression of the following markers in id2a MO-injected embryos: the early hepatoblast markers, hhex and prox1a (Field et al., 2003; Ober et al., 2006) , for hepatoblast specification and maintenance; and the hepatocyte markers, fabp10a, cp, and sepp1b, for hepatocyte differentiation and hepatic outgrowth. hhex and prox1a expression was detected in the livers of the MO-injected embryos at 36 hpf ( Fig. 3C and D, arrows) , suggesting that id2a does not regulate hepatoblast specification or its maintenance (Fig. 3C and D, arrows) . Hepatic fabp10a, cp, and sepp1b expression was also detected in the MO-injected embryos at 48 hpf (Fig. 3E-G, arrows) , suggesting that id2a does not regulate hepatocyte differentiation. However, the liver size was reduced following id2a knockdown, implicating id2a in regulating hepatic outgrowth. Additionally, since id2a is expressed strongly in the gut and intestinal regions during development ( Fig. 1A; bracket) , we examined the expression of cdx1b, an intestinal bulb marker (Cheng et al., 2008) , expecting a similar outgrowth phenotype as observed in the liver. As expected, lack of id2a had no effect on cdx1b induction; however, the intestinal bulb failed to grow at 48 hpf in id2a MO-injected embryos (Fig. 3H, brackets) , indicative of an intestinal outgrowth defect. We further sought to determine whether id2a knockdown resulted in a general outgrowth defect of all endoderm-derived organs or specific organs in which id2a is expressed. Since id2a is not expressed in the dorsal pancreas (Figs. 1A and S2A ), we performed WISH to examine the expression of insulin, which marks the pancreatic beta cells of the dorsal pancreas (Argenton et al., 1999) . We found no difference in the size of the dorsal pancreas between control and id2a MO-injected embryos (Fig. S2B) .
Previous studies have implicated ID proteins in the maintenance of neural stem cells. Id1 and Id3 double-knockout mice exhibit precocious neuronal differentiation, whereas ID2 overexpression in the chick hindbrain inhibits neuronal differentiation (Bai et al., 2007) . Thus, it is still possible that id2a knockdown may result in precocious hepatocyte differentiation. To test this possibility, we examined fabp10a expression at 36 hpf, when fabp10a expression is not yet detected in the livers of wild-type embryos. However, fabp10a expression was not detected in id2a MO-injected embryos (data not shown), ruling out this possibility. Moreover, we examined whether Id2a overexpression could increase liver size. However, liver size was not further increased in id2a mRNA-injected embryos at 72 hpf compared with controls ( Fig. S1E) , indicating that Id2a is not sufficient for liver outgrowth. Altogether, these data indicate that during liver development, id2a is not required for hepatoblast specification or hepatocyte differentiation, but rather for hepatic outgrowth. Moreover, the outgrowth defect observed in id2a MO-injected embryos may also apply to the development of other organ systems, such as the intestinal bulb.
id2a knockdown reduces liver size via decreased hepatoblast proliferation and increased cell death
To determine whether the small liver observed in id2a MO-injected embryos was caused by reduced proliferation and/or enhanced cell death, we conducted anti-phospho-Histone 3 (pH3) immunostaining and EdU labeling for proliferation and TUNEL labeling for cell death. Although the percentage of pH3 + cells among prox1a:YFP + hepatic cells in id2a MO-injected embryos at 40 hpf was not significantly different from that in controls, there was a trend of reduced pH3 + cell number in the MO-injected liver compared to the control liver (0-3 versus 3-5) ( Fig. 4A and B) . EdU labeling revealed about a 40% decrease in the percentage of EdU + cells among sox17:GFP + hepatic cells in id2a MO-injected embryos at 40 hpf compared with controls ( Fig. 4C and D) , indicating reduced proliferation. In addition, we observed TUNEL and Prox1 double-positive cells in id2a MO-injected embryos at 40 hpf, but not in controls ( Fig. 4E and F) . MO-mediated knockdown can often induce apoptosis mediated via aberrant p53 activation; thus, concurrent knockdown of tp53 can ameliorate apoptosis induced by MO off-targeting (Robu et al., 2007) . Therefore, we performed simultaneous knockdown of tp53 and id2a. We did not detect any differences in microphthalmic, microcephalic, or small liver phenotypes between single id2a and double id2a/tp53 MO-injected embryos at 60 hpf ( Fig. S1C and S1D ), indicating that id2a knockdown phenotypes are independent of the p53 pathway. Altogether, these data indicate that id2a regulates hepatic outgrowth by promoting hepatoblast proliferation and repressing cell death.
Discussion
In this study, we sought to determine the role of Id2a in liver development. We report three important findings. First, by using WISH followed by immunostaining, we discovered that id2a is initially expressed in the liver-forming region from 30 hpf and following hepatoblast differentiation at 48 hpf, id2a expression is restricted to BECs. Second, id2a knockdown did not affect hepatocyte differentiation or hepatoblast specification, which correlates with a lack of id2a liver expression during the hepatoblast specification stage (i.e., 22 hpf). Lastly, our data revealed that id2a knockdown inhibited hepatic outgrowth during development as supported by the reduced liver size in id2a MO-injected embryos.
Similar to the phenotype observed in id2a MO-injected embryos, in which hepatic outgrowth was compromised while hepatoblast specification and hepatocyte differentiation appeared unaffected, additional genes are also implicated in regulating hepatic outgrowth in zebrafish. Classified as a tumor suppressor gene that functions as a transcriptional activator, core promoter element binding protein (copeb; renamed as klf6a) is expressed in the zebrafish digestive organs, including the liver, the pancreas, and intestine. In copeb MO-injected embryos, the expansion of the liver is impaired (Zhao et al., 2010) . Moreover, the failure of hepatic outgrowth in copeb MO-injected larvae is also attributed to a decrease in cell proliferation, as observed in id2a MO-injected embryos (Zhao et al., 2010) . A similar phenotype is observed in the cell cycle modulator ubiquitin-like with PHD and ring finger domains 1 (uhrf1) mutants, which exhibit smaller livers as a result of a proliferation defect during the hepatic outgrowth phase (Sadler et al., 2007) . In addition, knockdown of either sfrp5 (Stuckenholz et al., 2013) or nav3a (Klein et al., 2011 ) also results in a defect in hepatoblast outgrowth and subsequent liver size in 40-hpf zebrafish embryos. These results correlate with the well-known role of ID proteins as master regulators of cell proliferation (Lasorella et al., 2014) , especially evident during early development.
Early development is a process defined by rapid cell proliferation followed by cell differentiation, generating distinct, mature tissues. Generally, Id expression is usually upregulated during the cell proliferation phase of early tissue development, and subsequently downregulated in mature, differentiated cells (Biggs et al., 1992; Ellmeier et al., 1992) . However, exceptions exist; therefore, ID protein-mediated proliferation is cell contextdependent. For example, overexpression of Id1, Id2, or Id3 in neural stem cells derived from the mouse embryonic forebrain maintains the cortical neural stem cells in a proliferative, self-renewing state, and simultaneously inhibits neuronal differentiation (Jung et al., 2010) . In contrast, upon differentiation of hematopoietic progenitor cells, Id2 expression increases (Cooper et al., 1997) . Previously, Uribe et al. reported on the role of id2a in zebrafish retinogenesis. Upon id2a knockdown, proliferative retinoblasts (in the S-phase) increased as mitotic retinoblasts (in the M-phase) decreased, which demonstrates a role of Id2a in regulating the S-to M-phase progression during the cell cycle (Uribe and Gross, 2010) . In contrast, we noted a significant decrease in the number of proliferating hepatoblasts at 40 hpf in id2a MO-injected embryos. As aforementioned, this phenotypic difference observed in proliferative cells during retinogenesis and liver development alludes to the dependence on cellular contexts in which id genes were studied. Nonetheless, id2a appears to play an important role in regulating proliferation in diverse tissue contexts including the developing liver.
In addition to proliferation, ID proteins also regulate apoptosis in a cell-dependent manner (Florio et al., 1998; Norton and Atherton, 1998) . While apoptosis is significantly increased in mammary epithelial cells of Id2 −/− pregnant mice (Mori et al., 2000) , overexpression of Id1, Id2, or Id3 induces apoptosis in serum-deprived rat embryonic fibroblasts (Deed et al., 1997) . In id2a MO-injected embryos, we observed a significant increase in the number of TUNEL-positive hepatoblasts at 40 hpf, highlighting the role of Id2a in regulating apoptosis in the developing liver.
Although intrahepatic biliary defects were also observed in id2a MO-injected embryos, it is unclear if the defects are either attributed to (1) a primary phenotype due to id2a knockdown or (2) a secondary phenotype due to compromised hepatic outgrowth. BEC-specific knockdown or knockout of id2a should conclusively establish a direct or indirect role of id2a in intrahepatic biliary morphogenesis. Currently, however, it is a challenge to create such a tool in zebrafish. As id2a expression is restricted in BECs during liver development, it will be interesting to explore the role of id2a in biliary-driven liver regeneration. Previously, we reported on a novel hepatocyte-specific genetic ablation model in zebrafish: following severe hepatocyte loss, BECs contribute to the repopulation of the liver (Choi et al., 2014) . Few reports have explored the role of ID2 in liver regeneration. In two different models of liver injury in rats, partial hepatectomy and bile duct ligation, Id2 is immediately upregulated during the hepatocyte priming phase and ID2 expression is detected in the proliferating hepatocytes, respectively (Rodriguez et al., 2006) . However, the role of Id2 in liver regeneration has not been reported yet. In addition, although ID2 has been shown to interact with various factors, including MyoD during myogenesis (Langlands et al., 1997) , future analysis should consider the currently unknown binding factor of Id2a in the developing zebrafish liver. Since id2a knockdown reduced the liver size, we speculate the binding partner of Id2a to function as a suppressor of hepatic outgrowth and a negative regulator of hepatoblast proliferation.
Our findings validate the role of id2a in promoting hepatic outgrowth and development. Future studies should explore the mechanism of action of Id2a, including its binding partner, in liver development. Discerning the molecular mechanisms regulating liver development will improve our comprehension of the biological relevance of hepatic diseases and methods to enhance innate liver regeneration.
Experimental procedures
Zebrafish maintenance
Embryos and adult zebrafish (Danio rerio) were raised and maintained under standard laboratory conditions (Westerfield, 2000) with protocols approved by the University of Pittsburgh IACUC.
Zebrafish strains
We used the following transgenic lines: TgBAC(prox1a:Citrine)
hu338 (Bussmann and Schulte-Merker, 2011) [referred to as Tg(prox1a:YFP)], Tg(EPV.Tp1-Mmu.Hbb:EGFP) um14 (Parsons et al., 2009) [referred to as Tg(Tp1:GFP)], Tg(kdrl:EGFP) s843 (Beis et al., 2005) [referred to as Tg(kdrl:GFP)], Tg(ptf1a:EGFP) jh1 (Godinho et al., 2005) [referred to as Tg(ptf1a:GFP)], Tg(sox17:GFP) s870 , and Tg(fabp10a:dsRed, ela31:GFP) gz12 [referred to as Tg(fabp10a:dsRed)].
Morpholino and mRNA injection
id2a MO (5′-GCCTTCATGTTGACAGCAGGATTTC-3′) (Uribe and Gross, 2010) and tp53 MO (5′-GCGCCATTGCTTTGCAAGAATTG-3′) (Langheinrich et al., 2002) were purchased from GeneTools (Philomath, OR, USA). 3-4 ng of id2a MO or 2 ng of tp53 MO was injected into one-cell stage embryos. For rescue experiments, 3 ng of the id2a MO and 150 pg of id2a mRNA, which is resistant to the id2a MO, was sequentially injected into one-cell stage embryos. The id2a mRNA was generated using the mMessage mMachine SP6 kit (Life Technologies, Grand Island, NY, USA).
Whole-mount in situ hybridization and immunohistochemistry
Whole-mount in situ hybridization was performed as previously described (Alexander et al., 1998) . cDNA from 24-hpf embryos was used as a template for PCR to amplify id1, id2a, id2b, id3, and id4 genes. We also used the following probes: hhex (Ho et al., 1999) , prox1 (Glasgow and Tomarev, 1998) , fabp10a (Her et al., 2003) , sepp1b (Kudoh et al., 2001) , cp (Korzh et al., 2001) , and cdx1b (Flores et al., 2008) . Whole-mount immunostaining was performed as previously described (Dong et al., 2007) , using the following antibodies: chicken polyclonal anti-GFP (1:100; Aves Labs, Tigard, OR, USA), rabbit polyclonal anti-Prox1 (1:1000; Millipore, Billerica, MA, USA), mouse monoclonal anti-Anxa4 (also named as 2 F11; 1:100; Abcam, Cambridge, MA USA), rabbit polyclonal anti-dsRed (1:200; Clontech, Mountain View, CA, USA), mouse monoclonal anti-phospho-Histone H3 (1:100; Cell Signaling, Danvers, MA, USA) and conjugated secondary antibodies, including Alexa Fluor 405, 488, 568, and 647 (1:300; Life Technologies, Grand Island, NY, USA). Hoechst 33342 (2.5 ng/ml; Sigma-Aldrich, St. Louis, MO, USA) was used for DNA staining. Zeiss LSM700 was used for confocal microscopy.
TUNEL and EdU assays
Apoptotic cell death was analyzed according to the protocol of the In Situ Cell Death Detection Kit, TMR Red (Roche, Switzerland). Following whole-mount immunostaining, TUNEL labeling was applied. Cell Proliferation was performed using the protocol outlined in the Click-iT EdU Alexa Fluor 647 Imaging Kit (Life Technologies, Grand Island, NY, USA). Larvae were incubated with EdU solution at 39 hpf for one hour, and at 40 hpf, they were harvested for EdU staining. Unpaired two-tailed Student's t-tests were used for statistical analysis; p b 0.05 was considered statistically significant.
